anhuienoside C

an active component of the Anemone flaccida preparation, Di Wu, used to treat rheumatism; structure in first source

Networked: 5 relevant articles (1 outcomes, 2 trials/studies)

1.	Experimental Arthritis 01/01/2017 - "Anhuienoside C Ameliorates Collagen-Induced Arthritis through Inhibition of MAPK and NF-κB Signaling Pathways."
2.	Ovarian Neoplasms (Ovarian Cancer) 07/01/2022 - "The present study was initiated to examine the anticancer effects of Anhuienoside C (AC) against ovarian cancer and postulates the possible molecular mechanism of its action. " 12/01/2023 - "Retraction Note: Anhuienoside C inhibits human ovarian cancer cell growth by inducing apoptosis, suppression of cell migration and invasion, and targeting PI3K/AKT/mTOR signaling pathway." 07/01/2022 - "Anhuienoside C inhibits human ovarian cancer cell growth by inducing apoptosis, suppression of cell migration and invasion, and targeting PI3K/AKT/mTOR signaling pathway."
3.	Diabetic Nephropathies (Diabetic Nephropathy) 07/01/2020 - "The present study evaluated the nephroprotective effects of anhuienoside C (AC) against diabetic nephropathy (DN) in rats. " 07/01/2020 - "Anhuienoside C Attenuates Podocyte Injury in Diabetic Nephropathy Rats."
4.	Rheumatic Diseases (Rheumatism) 03/01/2015 - "1.Anhuienoside C (A-C) is the main active component of the saponin exact of "Di Wu", an oral drug for rheumatism treatment in China. "